Vernalis to raise £68.5m 10/02/2012
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Bioplastics concern Biome Technologies has reduced first-half losses 40 per cent to £1.7 million and sees growing interest from the USA.
The company says an apparent 17 per cent turnover fall to $6.7 million in the six months to June reflects a move from 100 per cent to 50 per cent consolidation of a joint venture, Biotec JV and explains turnover on a comparable basis showed a 40 per cent increase, with its Stanelco radio frequency side nearly doubling sales.
Chief executive officer Paul Mines says pending European Union legislation favouring disposable packaging continues to work for Biome, which moved from the Main Market to AIM last month after raising £2.7 million at a lowly 0.125p. He adds the company, which until recently was called Stanelco, is finding 18 months of effort in the US market is now 'bearing fruit' in the food services and food processing sectors across the Pond.
According to Mines, a new high temperature food packaging product has met a 'reasonable response' and should benefit Biome's second-half performance. He says interest is picking up from electronics and durables companies in casings made in bio-based materials, with makers of razors and other personal care items also inquiring.
Observers suggest the company, which mostly sells to smaller and medium-sized concerns keen to boost their brands, is understood to be holding product trials with more than one leading European electronics group. With £4.7 million cash at the end of June, Biome could be heading towards profitability in 2012, argue some analysts.
Biome shares, which traded above 4p 10 years ago in their old Stanelco guise, now languish at 0.13p. They have speculative recovery appeal for the bold.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Magnolia Petroleum (MAGP) has acquired 800 acres in the Mississippi Lime formation in Oklahoma.
Gold explorer Condor Resources (CNR) has reported encouraging results from drilling at its La India project in Nicaragua.
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
Beleaguered travel operator Thomas Cook (TCG) has reported a loss of £91 million its first quarter also announcing the sale of its Indian division.